Griffith M - Search Results

1

Prolonged disease-free remission following rituximab and low-dose cyclophosphamide therapy for renal ANCA-associated vasculitis.

Mansfield N, Hamour S, Habib AM, Tarzi R, Levy J, Griffith M, Cairns T, Cook HT, Pusey CD, Salama AD. Mansfield N, et al. Among authors: griffith m. Nephrol Dial Transplant. 2011 Oct;26(10):3280-6. doi: 10.1093/ndt/gfr127. Epub 2011 Mar 17. Nephrol Dial Transplant. 2011. PMID: 21414973 Clinical Trial.

2

T cell responses to myeloperoxidase (MPO) and proteinase 3 (PR3) in patients with systemic vasculitis.

Griffith ME, Coulthart A, Pusey CD. Griffith ME, et al. Clin Exp Immunol. 1996 Feb;103(2):253-8. doi: 10.1046/j.1365-2249.1996.d01-629.x. Clin Exp Immunol. 1996. PMID: 8565308 Free PMC article.

3

C-antineutrophil cytoplasmic antibody positivity in vasculitis patients is associated with the Z allele of alpha-1-antitrypsin, and P-antineutrophil cytoplasmic antibody positivity with the S allele.

Griffith ME, Lovegrove JU, Gaskin G, Whitehouse DB, Pusey CD. Griffith ME, et al. Nephrol Dial Transplant. 1996 Mar;11(3):438-43. Nephrol Dial Transplant. 1996. PMID: 8671812

4

Classification, pathogenesis, and treatment of systemic vasculitis.

Griffith ME, Gaskin G, Pusey CD. Griffith ME, et al. Ren Fail. 1996 Sep;18(5):785-802. doi: 10.3109/08860229609047707. Ren Fail. 1996. PMID: 8903093 Free article. Review.

5

HLA genes in ANCA-associated vasculitides.

Griffith ME, Pusey CD. Griffith ME, et al. Exp Clin Immunogenet. 1997;14(3):196-205. Exp Clin Immunogenet. 1997. PMID: 9493788 Review.

6

Anti-neutrophil cytoplasmic antibodies (ANCA) from patients with systemic vasculitis recognize restricted epitopes of proteinase 3 involving the catalytic site.

Griffith ME, Coulthart A, Pemberton S, George AJ, Pusey CD. Griffith ME, et al. Clin Exp Immunol. 2001 Jan;123(1):170-7. doi: 10.1046/j.1365-2249.2001.01420.x. Clin Exp Immunol. 2001. PMID: 11168015 Free PMC article.

7

Cellular aspects of vasculitis--T cell-mediated aspects.

Griffith ME, Pusey CD. Griffith ME, et al. Springer Semin Immunopathol. 2001;23(3):287-98. doi: 10.1007/s002810100077. Springer Semin Immunopathol. 2001. PMID: 11591103 Review. No abstract available.

8

Five-year results of kidney transplantation under tacrolimus-based regimes: the persisting significance of vascular rejection.

Loucaidou M, McLean AG, Cairns TD, Griffith M, Hakim N, Palmer A, Papalois V, Van Tromp J, Loucaides C, Welsh KI, Taube D. Loucaidou M, et al. Among authors: griffith m. Transplantation. 2003 Oct 15;76(7):1120-3. doi: 10.1097/01.TP.0000076474.76480.A4. Transplantation. 2003. PMID: 14557763

9

Prospective study of TNFalpha blockade with infliximab in anti-neutrophil cytoplasmic antibody-associated systemic vasculitis.

Booth A, Harper L, Hammad T, Bacon P, Griffith M, Levy J, Savage C, Pusey C, Jayne D. Booth A, et al. Among authors: griffith m. J Am Soc Nephrol. 2004 Mar;15(3):717-21. doi: 10.1097/01.asn.0000114554.67106.28. J Am Soc Nephrol. 2004. PMID: 14978174 Clinical Trial.

10

Prolonged treatment with low-dose intravenous pulse cyclophosphamide may reduce rate of relapse in ANCA-associated vasculitis.

Dhaygude A, Griffith M, Cairns T, McLean A, Palmer A, Taube D. Dhaygude A, et al. Among authors: griffith m. Nephron Clin Pract. 2004;97(4):c154-9. doi: 10.1159/000079175. Nephron Clin Pract. 2004. PMID: 15331939 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,071 results

Search Page

Filters